"Nearly 1,8 billion people suffer from chronic respiratory diseases, and it is one of the biggest and fastest growing health problems in the world. Medicines and current treatment practices alone will not make patients symptomless. In addition, new tools need to be found that can be deployed on a large and effective scale.
WellO2 is a patented self-care device that can effectively relieve respiratory symptoms at home and improve lung function to boost performance. We have sold 110,000 devices with exceptional customer feedback, and the product’s efficacy and safety has been proven in clinical trials.
WellO2 is regularly used by top athletes, and in February 2024 Premier League club West Ham United decided to start using WellO2 and selected WellO2 as their Official Respiratory Supplier. We have started international sales in the Nordics, the UK, South Korea and Hong Kong. Research evidence, together with exceptional market feedback, is a strong basis for the decision to develop a medical device version of the product which enables access to the healthcare market globally.
We are now raising funding for boosting international growth and medical device development."
Tuomas Mattelmäki, CEO